MXCT
MaxCyte 2025 Financial Results Review
MaxCyte, Inc. (MXCT) posted a Q4 2025 GAAP loss of $0.09 per share, wider than the -$0.08 expected loss (10.3%…
MaxCyte Inc (MXCT) Q3 2022 Earnings Call
MaxCyte Inc (NASDAQ: MXCT) Q3 2022 Earnings Conference
MaxCyte Inc (MXCT) Q2 2022 earnings call
MaxCyte Inc (NASDAQ: MXCT) Q2 2022 Earnings Conference
MaxCyte Inc (MXCT) Q1 2022
MaxCyte Inc (NASDAQ: MXCT) Q1 2022 Earnings Conference
MaxCyte Inc (MXCT) Q4 2021 Earnings Conference Call
MaxCyte Inc (NASDAQ: MXCT) Q4 2021 Earnings Conference
MaxCyte Inc (MXCT) MaxCyte to Report Third Quarter 2021 Financial Results on November 10, 2021
MaxCyte Inc (NASDAQ: MXCT) Q3 2021 Earnings Conference
MaxCyte Inc (MXCT) MaxCyte to Report Second Quarter 2021 Financial Results on September 13, 2021
MaxCyte Inc (NASDAQ: MXCT) Q2 2021 Earnings Conference